C Peschle

Active 1975–2010

85
Papers
23,707
Citations
83
h-index
85
i10-index

Citations

Citations per year for C Peschle1974: 2 citations1978: 3 citations1979: 1 citations1980: 2 citations1981: 2 citations1982: 6 citations1983: 1 citations1984: 4 citations1985: 6 citations1986: 10 citations1987: 31 citations1988: 24 citations1989: 20 citations1990: 12 citations1991: 25 citations1992: 30 citations1993: 48 citations1994: 54 citations1995: 62 citations1996: 67 citations1997: 97 citations1998: 120 citations1999: 165 citations2000: 156 citations2001: 155 citations2002: 179 citations2003: 172 citations2004: 167 citations2005: 143 citations2006: 126 citations2007: 251 citations2008: 409 citations2009: 467 citations2010: 518 citations2011: 496 citations2012: 374 citations2013: 345 citations2014: 280 citations2015: 228 citations2016: 165 citations2017: 178 citations2018: 151 citations2019: 546 citations2020: 455 citations2021: 367 citations2022: 233 citations2023: 161 citations2024: 235 citations2025: 77 citations2026: 1 citations1975–1977: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,954 citing papers, 30.2% of this breakdownChina: 1,104 citing papers, 11.3% of this breakdownItaly: 815 citing papers, 8.3% of this breakdownGermany: 586 citing papers, 6% of this breakdownUnited Kingdom: 513 citing papers, 5.2% of this breakdownFrance: 362 citing papers, 3.7% of this breakdownJapan: 351 citing papers, 3.6% of this breakdownCanada: 300 citing papers, 3.1% of this breakdownAustralia: 231 citing papers, 2.4% of this breakdownNetherlands: 213 citing papers, 2.2% of this breakdownIndia: 177 citing papers, 1.8% of this breakdownSpain: 160 citing papers, 1.6% of this breakdown
0%30.2%Other 20.6%

Fields

  • Biochemistry, Genetics and Molecular Biology49.4%
  • Medicine40.5%
  • Immunology and Microbiology5.2%
  • Neuroscience2.7%
  • Engineering0.6%
  • Materials Science0.4%
  • Other1.2%

Topics

  • MicroRNA in disease regulation8.1%
  • Cancer Cells and Metastasis6.5%
  • Circular RNAs in diseases4.2%
  • Cancer-related molecular mechanisms research3.9%
  • Epigenetics and DNA Methylation2.6%
  • Acute Myeloid Leukemia Research1.9%
  • Other72.8%

Coauthors

All papers

Open in search
  1. Identification and expansion of human colon-cancer-initiating cells

    Authors: , , , , , , - Nature 2006 cited by 3,997

  2. MicroRNA-133 controls cardiac hypertrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2007 cited by 1,776

  3. Identification and expansion of the tumorigenic lung cancer stem cell population

    Authors: , , , , , , , , , - Cell Death and Differentiation 2007 cited by 1,696

  4. Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis

    Authors: , , , , , , , , , , , - Blood 2002 cited by 323

  5. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

    Authors: , , , , , , , , , , , , , - Nature Medicine 2008 cited by 984

  6. Chemotherapy resistance of glioblastoma stem cells

    Authors: , , , , , , , , , - Cell Death and Differentiation 2006 cited by 628

  7. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells

    Authors: , , , , , , , , , , - Cell 1993 cited by 611

  8. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

    Authors: , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 763

  9. Haemoglobin switching in human embryos: asynchrony of ζ → α and ε → γ-globin switches in primitive and definitive erythropoietic lineage

    Authors: , , , , , , , , , , , , - Nature 1985 cited by 226

  10. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 289

  11. Transferrin receptor 2 is frequently expressed in human cancer cell lines

    Authors: , , , , , , , , - Blood Cells Molecules and Diseases 2007 cited by 170

  12. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha

    Authors: , , , , , , , , , - The Journal of Immunology 1992 cited by 403

  13. Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlying the yolk sac--liver transition.

    Authors: , , , , , , , , - Journal of Clinical Investigation 1986 cited by 292

  14. Regulation of Cell Size and Contractile Function by AKT in Cardiomyocytes

    Authors: , , , , - Annals of the New York Academy of Sciences 2004 cited by 129

  15. Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM

    Authors: , , , , , , , , , , , - PLoS ONE 2008 cited by 386

  16. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

    Authors: , , , , , , , , , - Nature 1999 cited by 384

  17. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis

    Authors: , , , , , , , , , , , , , - Nature Cell Biology 2008 cited by 226

  18. Expression of Caveolin-1 Is Required for the Transport of Caveolin-2 to the Plasma Membrane

    Authors: , , , , , , , , , , , , - Journal of Biological Chemistry 1999 cited by 212

  19. Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer

    Authors: , , , , , , , , , - British Journal of Cancer 1995 cited by 198

  20. Interleukin-3 receptor in acute leukemia

    Authors: , , , , , - Leukemia 2003 cited by 117

  21. Chemotherapy-Induced Thrombocytopenia Derives from the Selective Death of Megakaryocyte Progenitors and Can Be Rescued by Stem Cell Factor

    Authors: , , , , , - Cancer Research 2007 cited by 94

  22. KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells

    Authors: , , , , , , , , , , , - Science 1999 cited by 485

  23. The Promyelocytic Leukemia Zinc Finger–MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms

    Authors: , , , , , , , , , , , - Cancer Research 2008 cited by 373

  24. Role of microRNAs in drug-resistant ovarian cancer cells

    Authors: , , , , , - Gynecologic Oncology 2008 cited by 359